|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00314 SIPAI HEALTH
Nominal 
1.590 +0.010 (+0.633%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 739,916 | -39.553% | 1,224,064 | 2,363,780 | 2,437,956 | 1,887,652 |
| Cost of Sales | (591,384) | -43.568% | (1,047,965) | (2,134,849) | (2,219,866) | (1,710,708) |
| Gross Profit | 148,532 | -15.654% | 176,099 | 228,931 | 218,090 | 176,944 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,081) | -19.435% | (2,583) | (3,291) | (1,829) | (90,104) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | (7,489) | -44.620% | (13,523) | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (72) | 24.138% | (58) | (157) | 0 | 81 | |
| Profit / (Loss) before Taxation | 43,608 | -- | (82,369) | (75,159) | (86,698) | (344,441) | |
| Taxation | (684) | -- | 1,230 | 508 | (609) | (1,546) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 370 | -95.958% | 9,154 | (3,551) | (5,014) | (340) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 43,294 | -- | (71,985) | (78,202) | (92,321) | (346,327) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (1,584) | -63.223% | (4,307) | (8,661) | (17,935) | (6,250) |
| Depreciation & Amortisation | 10,144 | -34.364% | 15,455 | 23,853 | 26,910 | 26,470 |
| Directors' Emoluments | -- | -- | -- | -- | -- | 43,947 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 7.000 | -- | -12.000 | -12.000 | -14.000 | -350.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.280 | -- | 1.328 | 1.962 | 2.371 | -- |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 43,294 |
| %Change | -- |
| EPS / (LPS) | RMB 0.070 |
| NBV Per Share (¥) | RMB 1.280 |